Health care utilization in chronic obstructive pulmonary disease. A case-control study in a health maintenance organization.
about
Comorbidities and Chronic Obstructive Pulmonary Disease: Prevalence, Influence on Outcomes, and ManagementManaging comorbidities in COPDAgeing and the epidemiology of multimorbidityRising Costs of COPD and the Potential for Maintenance Therapy to Slow the TrendNew clinical insights into chronic obstructive pulmonary disease and their implications for pharmacoeconomic analysesThe effect of an active implementation of a disease management programme for chronic obstructive pulmonary disease on healthcare utilization--a cluster-randomised controlled trialMeasuring health-related quality of life in chronic obstructive pulmonary disease: properties of the EQ-5D-5L and PROMIS-43 short formComorbidities in obstructive lung disease in Korea: data from the fourth and fifth Korean National Health and Nutrition Examination Survey.Direct costs of COPD in the U.S.: an analysis of Medical Expenditure Panel Survey (MEPS) data.The influence of heart disease on characteristics, quality of life, use of health resources, and costs of COPD in primary care settingsClinical and individual factors associated with smoking quit attempts among adults with COPD: do factors vary with regard to race?Is periodontitis a comorbidity of COPD or can associations be explained by shared risk factors/behaviors?Surveillance of chronic obstructive pulmonary disease in high-risk individuals by using regional lung cancer mass screening.Identifying and characterizing COPD patients in US managed care. A retrospective, cross-sectional analysis of administrative claims data.Physical activity, health status and risk of hospitalization in patients with severe chronic obstructive pulmonary diseaseSafety-net facilities and hospitalization rates of chronic obstructive pulmonary disease: a cross-sectional analysis of the 2007 Texas Health Care Information Council inpatient data.Chronic obstructive pulmonary disease and the metabolic syndrome: Consequences of a dual threatThe relationship between telomere length and mortality in chronic obstructive pulmonary disease (COPD).The prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: a cross-sectional study using data from NHANES 1999-2008.Lack of association of ischemic heart disease with COPD when taking into account classical cardiovascular risk factors.Determinants of elevated healthcare utilization in patients with COPDGeographic disparity in COPD hospitalization rates among the Texas population.Factors predictive of airflow obstruction among veterans with presumed empirical diagnosis and treatment of COPDThe impact of chronic pain on direct medical utilization and costs in chronic obstructive pulmonary disease.Efficacy of a simple and inexpensive exercise training program for advanced chronic obstructive pulmonary disease patients in community hospitals.Chronic obstructive pulmonary disease, hospital visits, and comorbidities: National Survey of Residential Care Facilities, 2010.The validity of International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis codes for identifying patients hospitalized for COPD exacerbations.Cost-effectiveness of tiotropium versus usual care and glycopyrronium in the treatment of chronic obstructive pulmonary disease in SwedenSimulation-Based Estimates of the Effectiveness and Cost-Effectiveness of Pulmonary Rehabilitation in Patients with Chronic Obstructive Pulmonary Disease in France.A longitudinal, retrospective cohort study on the impact of roflumilast on exacerbations and economic burden among chronic obstructive pulmonary disease patients in the real worldEvaluation of pharmacotherapy of obstructive airway diseases in the Montenegrin outpatient care: comparison with two Scandinavian countries.Is hypercapnia associated with poor prognosis in chronic obstructive pulmonary disease? A long-term follow-up cohort study.Impact of exacerbations on health care cost and resource utilization in chronic obstructive pulmonary disease patients with chronic bronchitis from a predominantly Medicare population.New episodes of depression among Medicare beneficiaries with chronic obstructive pulmonary diseaseExplaining the link between access-to-care factors and health care resource utilization among individuals with COPD.Prevalence of renal and hepatobiliary disease, laboratory abnormalities, and potentially toxic medication exposures among persons with COPDAssessment of the economic burden of COPD in the U.S.: a review and synthesis of the literature.INDACO project: a pilot study on incidence of comorbidities in COPD patients referred to pneumology units.Evaluation of C-Reactive Protein in Patients with Chronic Obstructive Pulmonary DiseaseCost-effectiveness of tiotropium versus glycopyrronium in moderate to very severe chronic obstructive pulmonary disease in Canada, Spain, Sweden, and the UK.
P2860
Q26799659-CC24E48C-72F5-4288-B6FB-75F067A54D1EQ27005858-A3D59C93-24D2-4111-AA0F-E595C70F210CQ27012096-05462C67-3FFF-45DC-B9B9-EDDB3D20CF11Q27026708-DE8A9285-2546-40A9-9C35-24F139A733EFQ30419928-87B23ECA-F5B3-4EB3-B5EE-6867ED66D342Q30558719-7A2F15EB-1B88-4C19-9AAD-3A517CB14A76Q30581735-CFC9DFA9-40C4-4736-B20F-E97465AE2170Q30989356-40CC5996-2CF7-461B-AD67-20DD54C001F1Q31082713-69A0E210-5F5D-4303-9A89-6DAA45C4C784Q33532293-9BA17B32-B7A6-4299-BF5F-4FC70C2530F5Q33627890-CCEE37D9-9CC7-45E9-B4AC-F5B5D4315C4BQ33649907-1DF7DFFD-1ECB-4EDC-BC45-49A72A9308FEQ33821875-68BDB4AA-52B1-4077-A3FD-85582B314A5AQ33827577-D90824A4-8217-4FF3-A2AC-56AD29B09E6FQ33928124-D3B34A1D-FBED-43DB-95C9-B78ADA672FBEQ34089222-42FAF80D-1CCF-430B-A397-59B950B75963Q34228984-F02D94AC-1630-4E05-A6BA-5F3B16AC53CAQ34256492-23E773CB-49D0-4EAC-8AA2-3B4D4CFF74CEQ34303093-F1A56F6B-79B9-4F7E-BB2D-0014F61CE1D6Q34309085-F897C705-67F9-410C-B9D1-348815676B2EQ34547146-BBB461D0-A205-49FD-ABBA-18B00591994AQ34723177-CE79D4FA-C0CA-4A65-A682-F1FB11862AC8Q35041495-FC6BCB4F-9278-4CFB-B3C9-981735BA40FCQ35240174-4F2A01CF-B76C-4253-B97D-4A7B81D0E7E7Q35568331-37CE3AA5-C08D-4318-BC9A-A9526E7BFF21Q35636099-7BFC90F4-1DD3-4C4D-9C72-BAF220B0E38BQ35651848-61445428-CCF6-426F-81BC-FDDB755BE3CEQ35964698-C02EF295-E5F3-4483-982C-1C66E0278C18Q36057662-F0BB4345-0EC0-4A71-84C7-ED616F4DDA4BQ36156113-D38E6EDE-DCBF-4633-B46C-78B5D6B118D6Q36217698-4D2228F7-285B-4AE5-A49D-C891AD93E17EQ36374199-0592CAB5-2A3C-4559-8393-5554D4BCF7F6Q36394339-68F6A432-F730-4104-A159-85876819E559Q36594114-F8EC0944-E500-453B-A5E0-3CAB66643A48Q36624132-22F2C2EB-B25B-4A8E-80BC-4452364C47FEQ36694313-3E205CA2-3D23-449B-BF6B-9C5D9227B48EQ36760100-2C8904DF-101A-4576-BD9B-00F243DA0081Q36797618-E0CCB5ED-8C24-4E83-9C69-35B85DCAFA35Q36929346-8B90F171-45C4-4336-800F-B91420888B23Q37012197-72EC1761-CD21-413D-A73A-04B841E13AF2
P2860
Health care utilization in chronic obstructive pulmonary disease. A case-control study in a health maintenance organization.
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Health care utilization in chr ...... alth maintenance organization.
@ast
Health care utilization in chr ...... alth maintenance organization.
@en
Health care utilization in chr ...... alth maintenance organization.
@nl
type
label
Health care utilization in chr ...... alth maintenance organization.
@ast
Health care utilization in chr ...... alth maintenance organization.
@en
Health care utilization in chr ...... alth maintenance organization.
@nl
prefLabel
Health care utilization in chr ...... alth maintenance organization.
@ast
Health care utilization in chr ...... alth maintenance organization.
@en
Health care utilization in chr ...... alth maintenance organization.
@nl
P2093
P1476
Health care utilization in chr ...... alth maintenance organization.
@en
P2093
P304
P356
10.1001/ARCHINTE.160.17.2653
P407
P577
2000-09-01T00:00:00Z